Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets (2019 - 2026)
Aurinia Pharmaceuticals (AUPH) reported Other Non-Current Assets of $93,000 for Q2 2026, unchanged from $93,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Dating back to Q4 2019, Aurinia Pharmaceuticals' Other Non-Current Assets record includes 24 quarters.
- Other Non-Current Assets has declined for three consecutive years, with a five-year compound annual growth rate of -17.7% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $823,000 in FY2024 (-45.7%), $1.52 million in FY2023 (-88.6%), $13.34 million in FY2022 (+12.7%) and $11.84 million in FY2021.
- Five-year quarterly Other Non-Current Assets spans a low of $93,000 in Q2 2025 and a high of $13.36 million in Q1 2023.
- The high point for year-over-year Other Non-Current Assets in five years was Q1 2023 (growth of 12.8%); the low point was Q3 2025 (a decline of 89.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $93,000 (Q1 2026), $93,000 (Q4 2025) and $93,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Aurinia Pharmaceuticals | 2.20 Bn | 623.41 Mn | 76.67 Mn | 93,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | 823,000.00 |
| Dec 31, 2024 | 823,000.00 |
| Sep 30, 2024 | 868,000.00 |
| Jun 30, 2024 | 867,000.00 |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | 1.52 Mn |
| Mar 31, 2023 | 14.06 Mn |
| Dec 31, 2022 | 13.42 Mn |
| Sep 30, 2022 | 13.75 Mn |
| Jun 30, 2022 | 12.56 Mn |
| Mar 31, 2022 | 12.74 Mn |
| Dec 31, 2021 | 12.14 Mn |
| Sep 30, 2021 | 11.84 Mn |
API Access
Aurinia Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();